Clinical twisters: Addressing CVA prophylaxis

Article

This case study assesses the need for anticoagulation and the drugs of choice for prophylaxis against cerebrovascular accidents (strokes) in patients with previous CVAs of different origins.

Nancy L. Shapiro, Pharm.D., BCPSAimee Chevalier, Pharm.D.
Clinical Pharmacists, Antithrombosis Clinic
Clinical Assistant Professor, Dept. of Pharmacy Practice
University of Illinois at Chicago College of Pharmacy

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
© 2025 MJH Life Sciences

All rights reserved.